Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Customer One [Member] \| Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	15.00%		10.00%
Customer One [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	11.00%	26.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	10.00%
Customer Concentration Risk [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	10.00%